CFL2 and myopathy: To gain insight into the regulation of cofilin-2 activity by a myopathy-causing mutation in TPM3, we used the p.R91C substitution in Tpm3.12, which is associated with muscle weakness in patients [5] and causes the hypocontractile phenotype in vitro [13].